Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100481014 | 10048101 | 4 | F | 2003 | 20141229 | 20140331 | 20141231 | EXP | US-PFIZER INC-2014090055 | PFIZER | 65.00 | YR | F | Y | 73.00000 | KG | 20141231 | N | LW | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100481014 | 10048101 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | ORAL | 20MG AND 40MG, DAILY | D | 20702 | FILM-COATED TABLET | ||||||||
100481014 | 10048101 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | D | 20702 | FILM-COATED TABLET | ||||||||||
100481014 | 10048101 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | D | 20702 | FILM-COATED TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
100481014 | 10048101 | 1 | Low density lipoprotein increased |
100481014 | 10048101 | 2 | Cardiovascular event prophylaxis |
100481014 | 10048101 | 3 | Blood cholesterol increased |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
100481014 | 10048101 | OT |
100481014 | 10048101 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
100481014 | 10048101 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
100481014 | 10048101 | 1 | 2001 | 2008 | 0 |